(1) Controlled-Release PHEN/TPM in Severely Obese Adults (EQUIP) trial (obesity without comorbidities), (2) Controlled-Release Phentermine plus Topiramate Combination in Overweight and Obese Adults (CONQUER) trial (obesity with comorbidities), and (3) SEQUEL (2-year extension of CONQUER), were comprised of 7% of older adult participants across the trials, although the upper age limit was 70 [111,112,113]
Published analyses report contamination prevalence from 10% to 35% in some supplement categories
2018 Waiver Provisions: The waiver directly addresses the treatment gap where 87% of Indiana residents with substance use disorders dont receive specialty care
With a range of peptides and HGH options, you can experience targeted solutions designed to restore balance, promote repair, and optimize health
Preventative measures before and during treatment Its not about taking care of your skin after the treatment, what you do before Botox is also important